Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Tarnow

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Diabetologia|September 21, 2002
Total plasma homocysteine is associated with hypertension in Type I diabetic patientsS Neugebauer, L Tarnow, C Stehouwer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 18, 1999
The Trp64Arg amino acid polymorphism of the beta3-adrenergic receptor gene does not contribute to the genetic susceptibility of diabetic microvascular complications in Caucasian type 1 diabetic patientsL Tarnow, S A Urhammer, B Mottlau, et al.
Journal of Hypertension|June 1, 1996
Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studiesS Danilov, F Savoie, B Lenoir, et al.
BMJ (Clinical Research Ed.)|September 7, 1996
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up studyH H Parving, P Jacobsen, L Tarnow, et al.
BMJ (Clinical Research Ed.)|February 4, 1995
Short stature and diabetic nephropathyP Rossing, L Tarnow, F S Nielsen, et al.
Molecular Genetics and Metabolism|May 10, 2008
The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathyA Jorsal, L Tarnow, M Lajer, et al.
Ugeskrift for Laeger|September 19, 1998
[The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors]L Tarnow, H H Parving, P Jacobsen, et al.
Diabetes Care|December 1, 1996
Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathyL Tarnow, P Rossing, F S Nielsen, et al.
Diabetes Care|June 17, 2000
Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathyL Tarnow, P Rossing, F S Nielsen, et al.
Diabetes|March 1, 1997
Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatmentP Rossing, L Tarnow, S Boelskifte, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Diabetologia|September 21, 2002
Total plasma homocysteine is associated with hypertension in Type I diabetic patientsS Neugebauer, L Tarnow, C Stehouwer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 18, 1999
The Trp64Arg amino acid polymorphism of the beta3-adrenergic receptor gene does not contribute to the genetic susceptibility of diabetic microvascular complications in Caucasian type 1 diabetic patientsL Tarnow, S A Urhammer, B Mottlau, et al.
Journal of Hypertension|June 1, 1996
Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studiesS Danilov, F Savoie, B Lenoir, et al.
BMJ (Clinical Research Ed.)|September 7, 1996
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up studyH H Parving, P Jacobsen, L Tarnow, et al.
BMJ (Clinical Research Ed.)|February 4, 1995
Short stature and diabetic nephropathyP Rossing, L Tarnow, F S Nielsen, et al.
Molecular Genetics and Metabolism|May 10, 2008
The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathyA Jorsal, L Tarnow, M Lajer, et al.
Ugeskrift for Laeger|September 19, 1998
[The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors]L Tarnow, H H Parving, P Jacobsen, et al.
Diabetes Care|December 1, 1996
Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathyL Tarnow, P Rossing, F S Nielsen, et al.
Diabetes Care|June 17, 2000
Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathyL Tarnow, P Rossing, F S Nielsen, et al.
Diabetes|March 1, 1997
Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatmentP Rossing, L Tarnow, S Boelskifte, et al.
Pageof 11